Structure Determination of T Cell Protein-tyrosine Phosphatase*

Protein-tyrosine phosphatase 1B (PTP1B) has recently received much attention as a potential drug target in type 2 diabetes. This has in particular been spurred by the finding that PTP1B knockout mice show increased insulin sensitivity and resistance to diet-induced obesity. Surprisingly, the highly homologous T cell protein-tyrosine phosphatase (TC-PTP) has received much less attention, and no x-ray structure has been provided. We have previously co-crystallized PTP1B with a number of low molecular weight inhibitors that inhibit TC-PTP with similar efficiency. Unexpectedly, we were not able to co-crystallize TC-PTP with the same set of inhibitors. This seems to be due to a multimerization process where residues 130–132, the DDQ loop, from one molecule is inserted into the active site of the neighboring molecule, resulting in a continuous string of interacting TC-PTP molecules. Importantly, despite the high degree of functional and structural similarity between TC-PTP and PTP1B, we have been able to identify areas close to the active site that might be addressed to develop selective inhibitors of each enzyme.

[1]  J. Noel,et al.  Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-α , 1999, Nature.

[2]  B. Neel,et al.  Growth factor-inducible alternative splicing of nontransmembrane phosphotyrosine phosphatase PTP-1B pre-mRNA. , 1993, The Journal of biological chemistry.

[3]  J. Noel,et al.  Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization , 1996, Nature.

[4]  N. Tonks,et al.  Epidermal Growth Factor Receptor and the Adaptor Protein p52Shc Are Specific Substrates of T-Cell Protein Tyrosine Phosphatase , 1998, Molecular and Cellular Biology.

[5]  B. Neel,et al.  The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence , 1992, Cell.

[6]  E. Fauman,et al.  The X-ray Crystal Structures of Yersinia Tyrosine Phosphatase with Bound Tungstate and Nitrate , 1996, The Journal of Biological Chemistry.

[7]  E. Krebs,et al.  Suppression of v-fms-induced transformation by overexpression of a truncated T-cell protein tyrosine phosphatase. , 1993, Oncogene.

[8]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[9]  N. Tonks,et al.  The Noncatalytic C-terminal Segment of the T Cell Protein Tyrosine Phosphatase Regulates Activity via an Intramolecular Mechanism* , 1997, The Journal of Biological Chemistry.

[10]  T R Burke,et al.  Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics. , 1998, Biochemistry.

[11]  P G Drake,et al.  Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.

[12]  J. Frangioni,et al.  Calpain‐catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP‐1B) in human platelets. , 1993, The EMBO journal.

[13]  B. Neel,et al.  Cloning of a cDNA for a major human protein-tyrosine-phosphatase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  X Y Wang,et al.  Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. , 2001, Biochemistry.

[15]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[16]  Xinjian Yan,et al.  Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design. , 1996, Biochemistry.

[17]  D. Lawrence,et al.  The Active Site Specificity of the Yersinia Protein-tyrosine Phosphatase (*) , 1996, The Journal of Biological Chemistry.

[18]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[19]  R. Majeti,et al.  An Inactivating Point Mutation in the Inhibitory Wedge of CD45 Causes Lymphoproliferation and Autoimmunity , 2000, Cell.

[20]  N. Tonks,et al.  The Reciprocal Role of Egr-1 and Sp Family Proteins in Regulation of the PTP1B Promoter in Response to the p210 Bcr-Abl Oncoprotein-tyrosine Kinase* , 2001, The Journal of Biological Chemistry.

[21]  D. Barford,et al.  Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. den Hertog,et al.  Multiple Interactions between Receptor Protein-tyrosine Phosphatase (RPTP) α and Membrane-distal Protein-tyrosine Phosphatase Domains of Various RPTPs* , 2000, The Journal of Biological Chemistry.

[23]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[24]  N. Tonks,et al.  Characterization of the major protein-tyrosine-phosphatases of human placenta. , 1988, The Journal of biological chemistry.

[25]  B. Neel,et al.  Structural Determinants of SHP-2 Function and Specificity in Xenopus Mesoderm Induction , 1998, Molecular and Cellular Biology.

[26]  L. Wu,et al.  Probing the function of the conserved tryptophan in the flexible loop of the Yersinia protein-tyrosine phosphatase. , 2008, European journal of biochemistry.

[27]  N. Tonks,et al.  Purification of the major protein-tyrosine-phosphatases of human placenta. , 1988, The Journal of biological chemistry.

[28]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[29]  Z. Zhang,et al.  Structure, mechanism, and specificity of protein-tyrosine phosphatases. , 1997, Current topics in cellular regulation.

[30]  John Wagner,et al.  Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[31]  M. Tremblay,et al.  The T-cell protein tyrosine phosphatase. , 2000, Seminars in immunology.

[32]  P. Ekman,et al.  Quantification of subnanomolar amounts of phosphate bound to seryl and threonyl residues in phosphoproteins using alkaline hydrolysis and malachite green. , 1993, Analytical biochemistry.

[33]  B. Kemp,et al.  Cellular Stress Regulates the Nucleocytoplasmic Distribution of the Protein-tyrosine Phosphatase TCPTP* , 2001, The Journal of Biological Chemistry.

[34]  J. Morrison,et al.  Buffers of constant ionic strength for studying pH-dependent processes. , 1982, Methods in enzymology.

[35]  L. Iversen,et al.  Protein tyrosine phosphatases (PTPs) as drug targets: inhibitors of PTP-1B for the treatment of diabetes. , 2000, Current opinion in drug discovery & development.

[36]  D. Barford,et al.  Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography* , 1998, The Journal of Biological Chemistry.

[37]  E. Fauman,et al.  Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate , 1994, Nature.

[38]  S. Shoelson,et al.  Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.

[39]  O. Olsen,et al.  Residue 259 Is a Key Determinant of Substrate Specificity of Protein-tyrosine Phosphatases 1B and α* , 2000, The Journal of Biological Chemistry.

[40]  L. Iversen,et al.  2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine Phosphatases* , 2000, The Journal of Biological Chemistry.

[41]  Ole Hvilsted Olsen,et al.  Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B* , 2000, The Journal of Biological Chemistry.

[42]  J. den Hertog,et al.  Antibody‐induced dimerization of HARPTPα–EGFR chimera suggests a ligand dependent mechanism of regulation for RPTPα , 2000 .

[43]  J. Dixon,et al.  Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1. , 1997, Biochemistry.

[44]  E. Fischer,et al.  COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus , 1995, The Journal of cell biology.

[45]  B. Neel,et al.  Combinatorial control of the specificity of protein tyrosine phosphatases. , 2001, Current opinion in cell biology.

[46]  A. Ullrich,et al.  Both SH2 Domains Are Involved in Interaction of SHP-1 with the Epidermal Growth Factor Receptor but Cannot Confer Receptor-directed Activity to SHP-1/SHP-2 Chimera* , 1997, The Journal of Biological Chemistry.

[47]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[48]  Stevan R. Hubbard,et al.  Structure and autoregulation of the insulin-like growth factor 1 receptor kinase , 2001, Nature Structural Biology.

[49]  M. J. Newman,et al.  Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases. , 2001, Biochemistry.

[50]  D. Barford,et al.  Crystal structure of human protein tyrosine phosphatase 1B. , 1994, Science.

[51]  E. Krebs,et al.  cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.